brain neoplasms/cannabis

De link wordt op het klembord opgeslagen

Kies het sorteertype

Bladzijde 1 van 25 resultaten

The use of cannabis in supportive care and treatment of brain tumor.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

Cannabinoids are multitarget substances. Currently available are dronabinol (synthetic delta-9-tetrahydrocannabinol, THC), synthetic cannabidiol (CBD) the respective substances isolated and purified from cannabis, a refined extract, nabiximols (THC:CBD = 1.08:1.00); and nabilone, which is also

Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

The efficacy of cannabinoids against high-grade glioma in animal models, mediated by two specific receptors, CB1 and CB2, raised promises for targeted treatment of the most frequent and malignant primary brain tumors. Unlike the abundantly expressed CB1, the CB2 receptor shows a restricted

Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

OBJECTIVE To conduct a comprehensive search of the peer-reviewed literature to assess risk of cannabis-related mortality. METHODS Systematic peer-reviewed literature searches were conducted in Medline, EMBASE and PsycINFO to identify data on mortality associated with cannabis use. Search strings for

The expression level of cannabinoid receptors type 1 and 2 in the different types of astrocytomas

Alleen geregistreerde gebruikers kunnen artikelen vertalen

Astrocytomas, the most prevalent primary brain tumors, can be divided by histology and malignancy levels into four following types: pilocytic astrocytoma (grade I), diffuse fibrillary astrocytoma (grade II), anaplastic astrocytoma (grade III), and glioblastoma multiforme (grade IV). For high grade

A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumors

Alleen geregistreerde gebruikers kunnen artikelen vertalen

Background: Primary CNS tumors constitute a heterogeneous group of neoplasms that share a considerable morbidity and mortality rate. To help control tumor growth and clinical outcomes (overall survival, progression-free survival, quality

High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

Cannabinoids bind to two G-protein-coupled receptors, CB1 and CB2, expressed by neurons and cells of the immune system, respectively. Glioma cells (astrocyte-derived brain tumor cells) express cannabinoid receptors, and numerous in vitro and in vivo studies performed in rodents have concluded that

Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

Dexanabinol, HU-211, a synthetic cannabinoid devoid of psychotropic effects, improves neurological outcome in models of brain trauma, ischemia and meningitis. Recently, HU-211 was found to inhibit brain tumor necrosis factor (TNFalpha) production after head injury. In the present study, we

Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

Gliomas are the most important group of malignant primary brain tumors and one of the most aggressive forms of cancer. During the last years, several studies have demonstrated that cannabinoids induce apoptosis of glioma cells and inhibit angiogenesis of gliomas in vivo. As the effects of

Medical Cannabis Certification in a Large Pediatric Oncology Center.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

In Minnesota, medical cannabis was approved for use in 2014. From July 2015 to February 2019, our center certified 103 pediatric and young adult patients for the use of medical cannabis under the qualifying conditions of cancer and treatment-related symptoms. Here, we provide a review of the

In vivo type 2 cannabinoid receptor-targeted tumor optical imaging using a near infrared fluorescent probe.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

The type 2 cannabinoid receptor (CB2R) plays a vital role in carcinogenesis and progression and is emerging as a therapeutic target for cancers. However, the exact role of CB2R in cancer progression and therapy remains unclear. This has driven the increasing efforts to study CB2R and cancers using

Control of the cell survival/death decision by cannabinoids.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

Cannabinoids, the active components of Cannabis sativa (marijuana), and their derivatives produce a wide spectrum of central and peripheral effects, some of which may have clinical application. The discovery of specific cannabinoid receptors and a family of endogenous ligands of those receptors has

Hypothesis: cannabinoid therapy for the treatment of gliomas?

Alleen geregistreerde gebruikers kunnen artikelen vertalen

Gliomas, in particular glioblastoma multiforme or grade IV astrocytoma, are the most frequent class of malignant primary brain tumours and one of the most aggressive forms of cancer. Current therapeutic strategies for the treatment of glioblastoma multiforme are usually ineffective or just

Targeting astrocytomas and invading immune cells with cannabinoids: a promising therapeutic avenue.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

The last quarter century has borne witness to great advances in both the detection and treatment of numerous cancers. Even so, malignancies of the central nervous system, especially high-grade astrocytomas, continue to thwart our best efforts toward effective chemotherapeutic strategies. With

Cannabinoids as potential new therapy for the treatment of gliomas.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

Gliomas constitute the most frequent and malignant primary brain tumors. Current standard therapeutic strategies (surgery, radiotherapy and chemotherapeutics, e.g., temozolomide, carmustin or carboplatin) for their treatment are only palliative and survival diagnosis is normally 6-12 months. The

Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.

Alleen geregistreerde gebruikers kunnen artikelen vertalen

Herein we show that a majority of human brain tumor samples and cell lines over-expressed cannabinoid receptor CB1 as compared to normal human astrocytes (NHA), while uniformly expressed low levels of CB2. This finding prompted us to investigate the therapeutic exploitation of CB1 inactivation by

Vorige
1
2
De volgende

Word lid van onze
facebookpagina

Herbal & Natural Medicine

De meest complete database met geneeskrachtige kruiden, ondersteund door de wetenschap

Werkt in 55 talen
Kruidengeneesmiddelen gesteund door de wetenschap
Kruidenherkenning door beeld
Interactieve GPS-kaart - tag kruiden op locatie (binnenkort beschikbaar)
Lees wetenschappelijke publicaties met betrekking tot uw zoekopdracht
Zoek medicinale kruiden op hun effecten
Organiseer uw interesses en blijf op de hoogte van nieuwsonderzoek, klinische onderzoeken en patenten

Typ een symptoom of een ziekte en lees over kruiden die kunnen helpen, typ een kruid en zie ziekten en symptomen waartegen het wordt gebruikt.
* Alle informatie is gebaseerd op gepubliceerd wetenschappelijk onderzoek